Venetian blinds are crooked.
Lampposts have a squiggle in them. A light bulb will have a dent in it. Results from a recent international clinical trial show that the photodynamic therapy can delay progression of the most destructive form of macular degeneration. The results of this round of trials were so promising that the Food and Drug Administration approved verteporfin on April 13, making it the first drug available for treating wet macular degeneration. AMD is an incurable but painless condition that disrupts the eyesight of some 1.7 million Americans, most of whom are over age 65.